Alere Determine Combo HIV 1/2 Ag/Ab rapid test for HIV
Alere Australia has gained approval for the marketing in Australia of the Alere Determine Combo HIV 1/2 Ag/Ab rapid test for HIV. This marks the first approval for an innovative HIV assay to be included on the Australian Register of Therapeutic Goods (ARTG) for use in a point-of-care situation.
Marketing approval required lengthy scrutiny by the TGA of the scientific and clinical evidence supporting the test, including its accuracy when performed in near patient situations by healthcare professionals other than pathology laboratory scientists.
The point-of-care test offers significant benefits to patients and to healthcare workers in terms of convenience and rapid management of immediate clinical issues. It brings HIV testing technology right to the patient’s bedside.
Phone: 07 3363 7100
Amsbio Acepix FFPE tissue blocks
Amsbio has expanded its range of high-quality formalin-fixed, paraffin-embedded (FFPE) tissues...
Promega Paradyme 27GY STR System
The Paradyme 27GY STR System features a novel enzyme that reduces the most common type of...
Mercodia Insulin MBeads Assay
The assay is designed to offer high accuracy by specifically measuring human insulin while...
